17-50375810-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152463.4(EME1):c.602C>T(p.Pro201Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152463.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EME1 | NM_152463.4 | c.602C>T | p.Pro201Leu | missense_variant | 2/9 | ENST00000338165.9 | NP_689676.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EME1 | ENST00000338165.9 | c.602C>T | p.Pro201Leu | missense_variant | 2/9 | 2 | NM_152463.4 | ENSP00000339897 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251222Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135842
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461882Hom.: 0 Cov.: 34 AF XY: 0.0000234 AC XY: 17AN XY: 727242
GnomAD4 genome AF: 0.000250 AC: 38AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.602C>T (p.P201L) alteration is located in exon 2 (coding exon 1) of the EME1 gene. This alteration results from a C to T substitution at nucleotide position 602, causing the proline (P) at amino acid position 201 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at